KDR and neoplasm: It possesses two antineoplastic pathways: one acts directly through the inhibition of tumor proliferation by blocking the RAF/MEK/ERK-mediated cell signaling pathway, and the other indirectly inhibits angiogenesis by blocking VEGFR and PDGFR [24].